A novel approach for improvement of the aqueous solubility of poorly water soluble compounds applying coamorphous systems was investigated by application of the enantiomers of the chiral amino acid tryptophan (TRP) as the model system. (Co-)amorphization of various forms of crystalline TRP was achieved by ball milling. Solid state analysis demonstrated significant differences in the amorphization tendency and physical stability between the two TRP enantiomers alone, the TRP racemate and an equimolar physical mixture of D- and L-TRP (TRP conglomerate). Ball milling for 6 h was required to obtain fully amorphous plain D- and L-TRP, whereas the TRP racemate and the TRP conglomerate were transformed into their amorphous forms already within 90 and 60 min of ball milling, respectively. Physical stability of the co-amorphous TRP conglomerate was observed for up to 60 d at ambient conditions as well as 40 degrees C/0 % RH. In contrast, the amorphous TRP racemate showed a reduced physical stability under ambient conditions. Interestingly, the intrinsic dissolution rates of the amorphous TRP conglomerate and racemate were not higher than those of the respective crystalline forms. In conclusion, applying two enantiomers of a chiral compound may be a promising approach for fast amorphization of an API and for improving the physical stability of the resulting amorphous form.
机构:
Jilin Med Univ, Sch Pharm, Jilin 132013, Peoples R ChinaJilin Med Univ, Sch Pharm, Jilin 132013, Peoples R China
Zhang, Yan-Fei
Yao, Qian
论文数: 0引用数: 0
h-index: 0
机构:
Yanbian Univ, Coll Pharmaceut Sci, Yanji 133002, Peoples R ChinaJilin Med Univ, Sch Pharm, Jilin 132013, Peoples R China
Yao, Qian
Lin, Xiao-Ying
论文数: 0引用数: 0
h-index: 0
机构:
Jilin Med Univ, Sch Pharm, Jilin 132013, Peoples R ChinaJilin Med Univ, Sch Pharm, Jilin 132013, Peoples R China
Lin, Xiao-Ying
Ma, Ying-Hui
论文数: 0引用数: 0
h-index: 0
机构:
Jilin Med Univ, Sch Pharm, Jilin 132013, Peoples R ChinaJilin Med Univ, Sch Pharm, Jilin 132013, Peoples R China
Ma, Ying-Hui
Zhang, Hui-Feng
论文数: 0引用数: 0
h-index: 0
机构:
Jilin Med Univ, Sch Pharm, Jilin 132013, Peoples R ChinaJilin Med Univ, Sch Pharm, Jilin 132013, Peoples R China
Zhang, Hui-Feng
Yu, Huan
论文数: 0引用数: 0
h-index: 0
机构:
Jilin Med Univ, Sch Pharm, Jilin 132013, Peoples R ChinaJilin Med Univ, Sch Pharm, Jilin 132013, Peoples R China
Yu, Huan
Mu, Shang-Qiang
论文数: 0引用数: 0
h-index: 0
机构:
Jilin Med Univ, Affilittend Hosp, Jilin 132011, Peoples R ChinaJilin Med Univ, Sch Pharm, Jilin 132013, Peoples R China
Mu, Shang-Qiang
Zhang, Chuang
论文数: 0引用数: 0
h-index: 0
机构:
Jilin Med Univ, Sch Pharm, Jilin 132013, Peoples R ChinaJilin Med Univ, Sch Pharm, Jilin 132013, Peoples R China
Zhang, Chuang
Geng, Hao
论文数: 0引用数: 0
h-index: 0
机构:
Jilin Med Univ, Sch Pharm, Jilin 132013, Peoples R ChinaJilin Med Univ, Sch Pharm, Jilin 132013, Peoples R China
Geng, Hao
Hao, Cheng-Yi
论文数: 0引用数: 0
h-index: 0
机构:
Jilin Med Univ, Sch Pharm, Jilin 132013, Peoples R ChinaJilin Med Univ, Sch Pharm, Jilin 132013, Peoples R China
Hao, Cheng-Yi
Zuo, Li-Li
论文数: 0引用数: 0
h-index: 0
机构:
Jilin Med Univ, Sch Pharm, Jilin 132013, Peoples R ChinaJilin Med Univ, Sch Pharm, Jilin 132013, Peoples R China
Zuo, Li-Li
Wu, Di
论文数: 0引用数: 0
h-index: 0
机构:
Jilin Med Univ, Sch Pharm, Jilin 132013, Peoples R ChinaJilin Med Univ, Sch Pharm, Jilin 132013, Peoples R China
Wu, Di
Li, Yue
论文数: 0引用数: 0
h-index: 0
机构:
Yanbian Univ, Coll Pharmaceut Sci, Yanji 133002, Peoples R ChinaJilin Med Univ, Sch Pharm, Jilin 132013, Peoples R China
Li, Yue
Jin, Li-Li
论文数: 0引用数: 0
h-index: 0
机构:
Yanbian Univ, Coll Pharmaceut Sci, Yanji 133002, Peoples R ChinaJilin Med Univ, Sch Pharm, Jilin 132013, Peoples R China
Jin, Li-Li
Shi, Nian-Qiu
论文数: 0引用数: 0
h-index: 0
机构:
Jilin Med Univ, Sch Pharm, Jilin 132013, Peoples R China
Yanbian Univ, Coll Pharmaceut Sci, Yanji 133002, Peoples R ChinaJilin Med Univ, Sch Pharm, Jilin 132013, Peoples R China